Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns.

Lea IA, Jackson MA, Li X, Bailey S, Peddada SD, Dunnick JK.

Carcinogenesis. 2007 Sep;28(9):1851-8. Epub 2007 Aug 11. Review.

2.

Alterations of the TP53 gene in gastric and esophageal carcinogenesis.

Bellini MF, Cadamuro AC, Succi M, Proença MA, Silva AE.

J Biomed Biotechnol. 2012;2012:891961. doi: 10.1155/2012/891961. Epub 2012 Aug 7. Review.

3.

Genetic pathways of two types of gastric cancer.

Tahara E.

IARC Sci Publ. 2004;(157):327-49. Review.

PMID:
15055305
4.
5.

The TP53 gene, tobacco exposure, and lung cancer.

Toyooka S, Tsuda T, Gazdar AF.

Hum Mutat. 2003 Mar;21(3):229-39. Review.

PMID:
12619108
6.

[TP53 mutations and molecular epidemiology].

Otsuka K, Ishioka C.

Gan To Kagaku Ryoho. 2007 May;34(5):683-9. Review. Japanese.

PMID:
17496437
7.

TP53 and gastric carcinoma: a review.

Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A.

Hum Mutat. 2003 Mar;21(3):258-70. Review.

PMID:
12619111
8.

Molecular biology of colorectal cancer.

Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J.

Curr Probl Cancer. 1997 Sep-Oct;21(5):233-300. Review.

PMID:
9438104
9.

[Colorectal oncogenesis].

Laurent-Puig P, Agostini J, Maley K.

Bull Cancer. 2010 Nov;97(11):1311-21. doi: 10.1684/bdc.2010.1216. Review. French.

11.

Somatic mutations in cancer: Stochastic versus predictable.

Gold B.

Mutat Res. 2017 Feb;814:37-46. doi: 10.1016/j.mrgentox.2016.12.006. Epub 2017 Jan 7. Review.

PMID:
28137366
12.

Tissue, cell and stage specificity of (epi)mutations in cancers.

Sieber OM, Tomlinson SR, Tomlinson IP.

Nat Rev Cancer. 2005 Aug;5(8):649-55. Review.

PMID:
16056260

Supplemental Content

Support Center